BACKGROUND
Screening for premalignant lesions or early invasive disease has the potential to reduce mortality from cancer. Potential screening tests for malignancy include measurement of (bio)markers.
BACKGROUND
The literature relevant to the use of biomarkers as screening tests for cancer was